MehmetAkceMD

PubMed

• Safety and Efficacy of Concurrent Atezolizumab/Bevacizumab or Nivolumab Combination Therapy with Yttrium-90 Radioembolization of Advanced Unresectable Hepatocellular C...
  Howard Hussein Dabbous, Olivia Little, Olumide Babajide Gbolahan, Mehmet Akce, Meghan Allegra Lilly, Zachary Bercu, Nima Kokabi, Alexander Villalobos> ;Current Oncology. 2023 Nov 25
• 1 citations
  Advances in Immunotherapy for Hepatocellular Carcinoma (HCC).
  Fuat Bicer, Catrina Kure, Anil A Ozluk, Bassel F El-Rayes, Mehmet Akce> ;Current Oncology. 2023 Nov 7
• 1 citations
  Management of Older Adults With Colorectal Cancer: The Role of Geriatric Assessment.
  Ahmet Anil Ozluk, Darryl Outlaw, Mehmet Akce, Mackenzie E Fowler, Daniel L Hess, Smith Giri, Grant R Williams> ;Clinical Colorectal Cancer. 2023 Dec 1
• Implementation of the Web-Enabled Cancer & Aging Resilience Evaluation (WeCARE) in an outpatient oncology setting.
  Christian Harmon, Mackenzie Fowler, Smith Giri, Abigail Tucker, Mustafa Al-Obaidi, Gabrielle Rocque, Lisa Zubkoff, Laura Q Rogers, Tanya M Wildes, Mackenzi Pergolotti,...> ;Journal of Geriatric Oncology. 2023 Nov 1
• Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer.
  Mehmet Akce, Batoul Farran, Jeffrey M Switchenko, Manali Rupji, Sandra Kang, Lana Khalil, Amanda Ruggieri-Joyce, Brian Olson, Walid L Shaib, Christina Wu, Olatunji B A...> ;Journal for Immunotherapy of Cancer. 2023 Oct 1
• Association of emotional support with quality of life, mental health, and survival in older adults with gastrointestinal malignancies-Results from the CARE registry.
  Daniel Clausing, Mackenzie E Fowler, Christian Harmon, Abigail Tucker, Darryl Outlaw, Mehmet Akce, Bassel El-Rayes, Smith Giri, Grant R Williams> ;Cancer Medicine. 2023 Sep 1
• ASO Visual Abstact: NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-paclitaxel for Resectable, High-Risk Intrahepatic ...
  Shishir K Maithel, Jessica M Keilson, Hop S Tran Cao, Manali Rupji, Amit Mahipal, Bruce S Lin, Milind M Javle, Sean P Cleary, Mehmet Akce, Jeffrey M Switchenko, Flavio...> ;Annals of Surgical Oncology. 2023 Oct 1
• 7 citations
  NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma.
  Shishir K Maithel, Jessica M Keilson, Hop S Tran Cao, Manali Rupji, Amit Mahipal, Bruce S Lin, Milind M Javle, Sean P Cleary, Mehmet Akce, Jeffrey M Switchenko, Flavio...> ;Annals of Surgical Oncology. 2023 Oct 1
• 1 citations
  Use of Metformin and Survival in Patients with Hepatocellular Carcinoma (HCC) Undergoing Liver Directed Therapy: Analysis of a Nationwide Cancer Registry.
  Kumar Mukherjee, Mohammad Elsayed, Eshani Choksi, Mohammed F Loya, Richard Duszak, Mehmet Akce, Bill S Majdalany, Zachary L Bercu, Mircea Cristescu, Nima Kokabi> ;Cardiovascular and Interventional Radiology. 2023 Jul 1
• 3 citations
  Combinatorial targeting of immune checkpoints and epigenetic regulators for hepatocellular carcinoma therapy.
  Mehmet Akce, Bassel F El-Rayes, Narendra Wajapeyee> ;Oncogene. 2023 Mar 1
• Targeted therapy for intractable cancer on the basis of molecular profiles: An open-label, phase II basket trial (Long March Pathway).
  Xiao-Dong Jiao, Bao-Dong Qin, Zhan Wang, Ke Liu, Ying Wu, Yan Ling, Wen-Xing Qin, Miao-Miao Wang, Ling-Yan Yuan, Savio George Barreto, Anthony W Kim, Kimberley Mak, Ha...> ;Frontiers in Oncology. 2023 Jan 1
• Survival and Prognostic Factors in Patients With Pancreatic Colloid Carcinoma Compared With Pancreatic Ductal Adenocarcinoma.
  Lana Khalil, Zhonglu Huang, Katerina Zakka, Renjian Jiang, McKenna Penley, Olatunji B Alese, Walid L Shaib, Christina Wu, Madhusmita Behera, Michelle D Reid, Bassel F ...> ;Pancreas. 2023 Jan 1
• 1 citations
  Role of local therapy in the management of patients with metastatic anal squamous cell carcinoma: a National Cancer Database study.
  Rami P Atallah, Yining Zhang, Katerina Zakka, Renjian Jiang, Zhonglu Huang, Walid L Shaib, Maria Diab, Mehmet Akce, Christina Wu, Bassel F El-Rayes, Olatunji B Alese> ;Journal of Gastrointestinal Oncology. 2022 Oct 1
• 2 citations
  Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer.
  Lana Khalil, Xingyu Gao, Jeffrey M Switchenko, Olatunji B Alese, Mehmet Akce, Christina Wu, Maria Diab, Bassel F El-Rayes, Walid L Shaib> ;The Oncologist. 2022 Sep 2
• 19 citations
  Evolving Role of Immunotherapy in Advanced Biliary Tract Cancers.
  Sandra Kang, Bassel F El-Rayes, Mehmet Akce> ;Cancers. 2022 Mar 29
• 3 citations
  Neoadjuvant treatment of pancreatic carcinosarcoma: a case report and review of literature.
  Chloe S Lalonde, Linyuan Wang, Brian Quigley, Pretesh Patel, Shishir K Maithel, Bassel F El-Rayes, Mehmet Akce> ;Chinese Clinical Oncology. 2022 Feb 1
• 2 citations
  Role of Resection of the Primary in Metastatic Well-Differentiated Neuroendocrine Tumors.
  Walid L Shaib, Katerina Zakka, McKenna Penley, Renjian Jiang, Mehmet Akce, Christina Wu, Shishir K Maithel, Juan M Sarmiento, David Kooby, Madhusmita Behera, Olatunji ...> ;Pancreas. 2022 Jan 18
• 12 citations
  Frontline therapy for advanced hepatocellular carcinoma: an update.
  Mehmet Akce, Bassel F El-Rayes, Tanios S Bekaii-Saab> ;Therapeutic Advances in Gastroenterology. 2022 Jan 1
• 5 citations
  Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors.
  Mohammed B Allaw, Jeffrey M Switchenko, Lana Khalil, Christina Wu, Olatunji B Alese, Mehmet Akce, Amber Draper, Aaron T Jones, Bassel El-Rayes, Walid Shaib> ;Oncology. 2022 Jan 1
• 1 citations
  Rapidly Evolving Landscape and Future Horizons in Hepatocellular Carcinoma in the Era of Immuno-Oncology.
  Sandra Mirie Kang, Lana Khalil, Bassel F El-Rayes, Mehmet Akce> ;Frontiers in Oncology. 2022 Jan 1
• 1 citations
  Successful Liver Transplantation of Recurrent Fibrolamellar Carcinoma following Clinical and Pathologic Complete Response to Triple Immunochemotherapy: A Case Report.
  Sandra Kang, Joseph Magliocca, Marty Sellers, Giorgio Roccaro, Wei Zheng, Melina Pectasides, Amber Draper, Jessica Guadagno, Bassel El-Rayes, Mehmet Akce> ;Oncology Research and Treatment. 2022 Jan 1
• 6 citations
  High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon Cancer
  Amr Mohamed, Renjian Jiang, Philip A. Philip, Maria Diab, Madhusmita Behera, Christina Wu, Olatunji B. Alese, Walid L. Shaib, Tyra M. Gaines, Glen G. Balch, Bassel F. ...> ;Frontiers in Oncology. 2021 Oct 25
• 1 citations
  Negative enrichment of circulating tumor cells from unmanipulated whole blood with a 3D printed device.
  Chia-Heng Chu, Ruxiu Liu, Tevhide Ozkaya-Ahmadov, Brandi E. Swain, Mert Boya, Bassel F. El-Rayes, Mehmet Akce, Mehmet Asim Bilen, Omer Kucuk, A. Fatih Sarioglu> ;Scientific Reports. 2021 Oct 18
• 6 citations
  Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single-arm, phase 2 st...
  James J. Harding, Tsai Sheng Yang, Yen Yang Chen, Yin Hsun Feng, Chia Jui Yen, Ching Liang Ho, Wen Tsung Huang, Imane El Dika, Mehmet Akce, Benjamin R. Tan, Stacey A. ...> ;Cancer. 2021 Aug 20
• 8 citations
  Pharmacokinetics and safety of niraparib in patients with moderate hepatic impairment
  Mehmet Akce, Anthony B. El-Khoueiry, Sarina Anne Piha-Paul, Emeline Bacque, Peng Pan, Zhi-Yi Zhang, Reginald Ewesuedo, Divya Gupta, Yongqiang Tang, Ashley Milton, Stef...> ;Cancer Chemotherapy and Pharmacology. 2021 Jul 29
• Join now to see all

Journal Articles

• The Potential of CAR T Cell Therapy in Pancreatic Cancer  
  Mehmet Akce, Mohammad Y Zaidi, Edmund K Waller, Frontiers in Neurology

Lectures

• Impact of high-risk features for stage II adenocarcinoma of the appendix. 
  ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
• The impact of inflammatory biomarkers, BMI, and sarcopenia on survival in advanced hepatocellular carcinoma treated with immunotherapy. 
  ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
• Phase Ib trial of pembrolizumab and XL888 in patients with advanced gastrointestinal malignancies: Results of the dose-escalation phase. 
  ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020